Search Results

Filter
  • 1-10 of  311 results for ""CHEMORADIOTHERAPY""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort.

  • Authors : Auclin E; Department of Hepato-Gastroenterology and Gastrointestinal Oncology, Université de Paris, Paris Descartes University, Hôpital Européen Georges Pompidou, Paris, France.; Department of Medical and Thoracic Oncology, Université de Paris, Hôpital Européen Georges Pompidou, Paris, France.

Subjects: Chemoradiotherapy*/Chemoradiotherapy*/Chemoradiotherapy*/methods; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

  • Source: British journal of cancer [Br J Cancer] 2021 Jun; Vol. 124 (12), pp. 1941-1948. Date of Electronic Publication: 2021 Mar 26.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Early metabolic response to chemoradiotherapy by interim FDG PET/CT is associated with better overall survival and histological response in esophageal cancers.

  • Authors : Hammoudi N; Department of Radiation Oncology, Saint Louis Hospital, Paris, France.; Hennequin C

Subjects: Chemoradiotherapy*; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*diagnostic imaging ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*mortality

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2019 Jun; Vol. 51 (6), pp.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX.

  • Authors : Lledo G; Gastroenterology Department, Private Hospital Jean Mermoz, Lyon, France; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France. Electronic address: .

Subjects: Chemoradiotherapy*/Chemoradiotherapy*/Chemoradiotherapy*/adverse effects; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Cetuximab/Cetuximab/Cetuximab/*administration & dosage Folfox protocol

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2016 Mar; Vol. 56, pp. 115-121. Date of Electronic Publication: 2016 Feb 02.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prognostic value of posttreatment FEDG-PET imaging following combined chemoradiation therapy in locally advanced cervical cancer.

  • Authors : Knight S; Department of Obstetrics and Gynaecology, Hôpital Nord, APHM, Aix-Marseille University (AMU), Univ Avignon, CNRS, IRD, IMBE UMR 7263, 13397, Marseille, France.; Mancini J

Subjects: Chemoradiotherapy* ; Prognosis* ; Treatment Outcome*

  • Source: Journal of gynecology obstetrics and human reproduction [J Gynecol Obstet Hum Reprod] 2020 Oct; Vol. 49 (8), pp. 101774. Date of Electronic Publication: 2020 Apr 21.Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 101701588 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Chemoradiation in rectal squamous cell carcinoma: Bi-institutional case series.

  • Authors : Loganadane G; Department of Radiation Oncology, Tenon Hospital, Hôpitaux Universitaires Est Parisien, Pierre and Marie Curie Paris 6 University, Paris, France.; Servagi-Vernat S

Subjects: Chemoradiotherapy*/Chemoradiotherapy*/Chemoradiotherapy*/adverse effects ; Chemoradiotherapy*/Chemoradiotherapy*/Chemoradiotherapy*/mortality ; Radiotherapy, Conformal*/Radiotherapy, Conformal*/Radiotherapy, Conformal*/adverse effects

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2016 May; Vol. 58, pp. 83-9. Date of Electronic Publication: 2016 Mar 11.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.

  • Authors : Boustani J; Department of Radiation Oncology, University Hospital Jean Minjoz, Besançon, France; Department of Radiation Oncology, Unicancer-Georges François Leclerc Cancer Center, Dijon, France. Electronic address: .

Subjects: Quality Assurance, Health Care*; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*diagnostic imaging ; Chemoradiotherapy/Chemoradiotherapy/Chemoradiotherapy/*standards Folfox protocol

  • Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Oct 01; Vol. 105 (2), pp. 329-337. Date of Electronic Publication: 2019 Jul 09.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Postoperative chemotherapy followed by conformal concomitant chemoradiotherapy in high-risk gastric cancer.

  • Authors : Quero L; Department of Radiation Oncology, Saint-Louis Hospital, Paris, France. ; Bouchbika Z

Subjects: Gastrectomy*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

  • Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2012 Jun 01; Vol. 83 (2), pp. 574-80. Date of Electronic Publication: 2011 Nov 16.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06).

  • Authors : Locher C; Service de Pneumologie, GHEF site de Meaux, France.; Pourel N

Subjects: Chemoradiotherapy*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*epidemiology

  • Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2018 Jul; Vol. 121, pp. 25-29. Date of Electronic Publication: 2018 Apr 22.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer.

  • Authors : Deutsch E; Department of Radiation Oncology; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif

Subjects: Radiotherapy, Conformal*/Radiotherapy, Conformal*/Radiotherapy, Conformal*/adverse effects ; Radiotherapy, Conformal*/Radiotherapy, Conformal*/Radiotherapy, Conformal*/mortality; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage

  • Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2015 Jun; Vol. 26 (6), pp. 1223-1229. Date of Electronic Publication: 2015 Feb 20.Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041

Record details

×
Academic Journal

Cardiovascular disease events within 5 years after a diagnosis of breast cancer.

  • Authors : Mery B; Department of Medical Oncology, Lucien Neuwirth Cancer Institute, 42270, SAINT PRIEST EN JAREZ, France. .; Fouilloux A

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*therapy ; Carcinoma, Ductal, Breast/Carcinoma, Ductal, Breast/Carcinoma, Ductal, Breast/*therapy ; Carcinoma, Lobular/Carcinoma, Lobular/Carcinoma, Lobular/*therapy

  • Source: BMC cancer [BMC Cancer] 2020 Apr 21; Vol. 20 (1), pp. 337. Date of Electronic Publication: 2020 Apr 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
  • 1-10 of  311 results for ""CHEMORADIOTHERAPY""